Profilo
Gregory D.
Kunst is currently Chief Executive Officer & Director at Valitor, Inc. since 2025 and Director at Pr3vent, Inc. Former positions include Co-Chief Executive Officer & Director at Aurion Biotech, Inc., Global Marketing Director at Alcon, Inc., and Vice President-Global Marketing at Glaukos Corp.
Education includes an MBA from Vanderbilt University and an undergraduate degree from Brigham Young University.
Posizioni attive di Gregory Kunst
| Società | Posizione | Inizio |
|---|---|---|
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Direttore/Membro del Consiglio | - |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins | Amministratore Delegato | 17/10/2025 |
Precedenti posizioni note di Gregory Kunst
| Società | Posizione | Fine |
|---|---|---|
| GLAUKOS CORPORATION | Vendite & Marketing | - |
Aurion Biotech, Inc.
Aurion Biotech, Inc. BiotechnologyHealth Technology Develops advanced cell therapies to treat eye diseases | Amministratore Delegato | - |
Formazione di Gregory Kunst
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 6 |
|---|---|
Glaukos Corp.
Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins | Health Technology |
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Health Services |
Aurion Biotech, Inc.
Aurion Biotech, Inc. BiotechnologyHealth Technology Develops advanced cell therapies to treat eye diseases | Health Technology |
















